Malattie autoimmuni del fegato e delle vie biliari

Responsabile scientifico/Coordinatore – Prof. Luigi Muratori

Attività scientifica

Caratterizzazione clinica, sierologica, istologica, genetica di epatite autoimmune, colangite biliare primitiva, colangite sclerosante primitiva, sindromi overlap; ricerca di fattori predittivi di risposta terapeutica e di prognosi

Collaborazioni nazionali e internazionali 

Prof. Diego Vergani, Dott. Cumali Efe, Prof. Eric Gershwin

Produzione scientifica 

1. Zachou K, Muratori P, Koukoulis GK et al. Review article: autoimmune hepatitis - current management and challenges. Aliment Pharmacol Ther. 2013;38:887-913.
2. Muratori L, Longhi MS. The interplay between regulatory and effector T cells in autoimmune hepatitis: Implications for innovative treatment strategies. J Autoimmun. 2013;46:74-80.
3. Efe C, Ozaslan E, Heurgue-Berlot A et al. Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis. Eur J Gastroenterol Hepatol. 2014;26:532-537.
4. Ozaslan E, Efe C, Heurgué-Berlot A et al. Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis. Clin Gastroenterol Hepatol. 2014;12:863-869.
5. Quarneti C, Muratori P, Lalanne C et al. Fatigue and pruritus at onset identify a more aggressive subset of primary biliary cirrhosis. Liver Int. 2015;35:636-641.
6. Muratori L, Deleonardi G, Lalanne C et al. Autoantibodies in Autoimmune Hepatitis. Dig Dis. 2015;33 Suppl 2:65-69.
7. Muratori P, Fabbri A, Lalanne C, Lenzi M, Muratori L. Autoimmune liver disease and concomitant extrahepatic autoimmune disease. Eur J Gastroenterol Hepatol. 2015;27:1175-1179.
8. Muratori P, Lalanne C, Fabbri A, Cassani F, Lenzi M, Muratori L. Type 1 and type 2 autoimmune hepatitis in adults share the same clinical phenotype. Aliment Pharmacol Ther. 2015;41:1281-1287.
9. Muratori P, Lalanne C, Barbato E et al. Features and Progression of Asymptomatic Autoimmune Hepatitis in Italy. Clin Gastroenterol Hepatol. 2016;14:139-146.
10. Muratori P, Lalanne C, Bianchi G, Lenzi M, Muratori L. Predictive factors of poor response to therapy in Autoimmune Hepatitis. Dig Liver Dis. 2016;48:1078-1081.
11. Muratori P, Efe C, Muratori L et al. Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study. Eur J Gastroenterol Hepatol. 2017
12. Muratori P, Lenzi M, Migliori M, Muratori L. Antimitochondrial antibodies positive autoimmune hepatitis with acute onset. Scand J Gastroenterol. 2017.